Prosthetic joint infection: Challenges of diagnosis and treatment

ANZ Journal of Surgery

Volumn 81, Issue 1-2, 2011, Pages 32-39

  Peel, Trisha N ^a   Buising, Kirsty L ^b   Choong, Peter F M ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Arthroplasty infection; Bone and joint infection; Infectious disease; Orthopaedic surgery

Indexed keywords

ARTICLE; HIP ARTHROPLASTY; HIP PROSTHESIS; HUMAN; INFECTION; KNEE ARTHROPLASTY; KNEE PROSTHESIS; METHODOLOGY; RISK FACTOR;

ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; HIP PROSTHESIS; HUMANS; KNEE PROSTHESIS; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS;

EID: 79551659760     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2010.05541.x     Document Type: Article

References (114)

1. Graves S, Davidson D, de Steiger R, Tomkins A. Australian Orthopaedic Association National Joint Replacement Registry Annual Report 2009. Sydney, Australia: Australian Medical Association, 2009; 1914. Adelaide, 1-200.
2. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Joint Surg. Am. 2007; 89: 780-5.
3. Ahnfelt L, Herberts P, Malchau H, Andersson GBJ. Prognosis of total hip replacement. Acta Orthop. Scand. 1990; 61: 2-26.
4. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N. Engl. J. Med. 2004; 351: 1645-54.
5. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J. Bone Joint Surg. Am. 2005; 87: 1746-51.
6. Berbari EF, Hanssen AD, Duffy MC etal. Risk factors for prosthetic joint infection: case-control study. Clin. Infect. Dis. 1998; 27: 1247-54.
7. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J. Arthroplasty. 2008; 23: 984-91.
8. Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin. Orthop. Relat. Res. 2010; 468: 52-6.
9. Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J. Arthroplasty. 2009; 24 (Suppl.): 105-9.
10. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin. Orthop. Relat. Res. 2008; 466: 1710-5.
11. Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare EP. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J. Bone Joint Surg. Am. 2007; 89: 33-8.
12. Dowsey MM, Choong PFM. Obesity is a major risk factor for prosthetic infection after primary hip arthroplasty. Clin. Orthop. Relat. Res. 2008; 466: 153-8.
13. Yang K, Yeo SJ, Lee BP, Lo NN. Total knee arthroplasty in diabetic patients: a study of 109 consecutive cases. J. Arthroplasty. 2001; 16: 102-6.
14. Poss R, Thornhill TS, Ewald FC, Thomas WH, Batte NJ, Sledge CB. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin. Orthop. Relat. Res. 1984; 182: 117-117.
15. Bengtson S, Knutson K. The infected knee arthroplasty. Acta Orthop. Scand. 1991; 62: 301-11.
16. Berbari EF, Osmon DR, Duffy MCT etal. Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin. Infect. Dis. 2006; 42: 216-23.
17. Surin VV, Sundholm K, Backman L. Infection after total hip replacement. J. Bone Joint Surg. Br. 1983; 65: 412-8.
18. Wymenga AB, van Horn JR, Theeuwes A, Muytjens HL, Slooff TJ. Perioperative factors associated with septic arthritis after arthroplasty. Prospective multicenter study of 362 knee and 2651 hip operations. Acta Orthop. Scand. 1992; 63: 665-71.
19. Wilson MG, Kelley K, Thornhill TS. Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. J. Bone Joint Surg. Am. 1990; 72: 878-83.
20. Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I, Atkins BL. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J. Infect. 2007; 55: 1-7.
21. Sharma D, Douglas J, Coulter C, Weinrauch P, Crawford R. Microbiology of infected arthroplasty: implications for empiric peri-operative antibiotics. J. Orthop. Surg. (Hong Kong) 2008; 16: 339-42.
22. Pandey R, Berendt AR, Athanasou NA. Histological and microbiological findings in non-infected and infected revision arthroplasty tissues. Arch. Orthop. Trauma Surg. 2000; 120: 570-4.
23. Steckelberg JM, Osmon DR. Prosthetic Joint Infections. In: Waldvogel FA, Bisno AL (eds). Infections Associated with Indwelling Medical Devices. Washington, DC: ASM Press, 2000; 173-209.
24. Fitzgerald RH, Nolan DR, Ilstrup DM, E. R, Washington JA, Coventry MB. Deep wound sepsis following total hip arthroplasty. J. Bone Joint Surg. Am. 1977; 59: 847-847.
25. McDonald DJ, Fitzgerald RH, Ilstrup DM. Two-stage reconstruction of a total hip arthroplasty because of infection. J. Bone Joint Surg. Am. 1989; 71: 828-34.
26. Dodson CC, Craig EV, Cordasco Fa etal. Propionibacterium acnes infection after shoulder arthroplasty: a diagnostic challenge. J. Shoulder Elbow Surg. 2010; 19: 303-7.
27. Piper KE, Jacobson MJ, Cofield RH etal. Microbiologic diagnosis of prosthetic shoulder infection by use of implant sonication. J. Clin. Microbiol. 2009; 47: 1878-84.
28. Southwood RT, Rice JL, McDonald PJ, Hakendorf PH, Rozenbilds MA. Infection in experimental hip arthroplasties. J. Bone Joint Surg. Br. 1985; 67: 229-31.
29. Murdoch DR, Roberts SA, Fowler VG Jr etal. Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin. Infect. Dis. 2001; 32: 647-9.
30. Deacon JM, Pagliaro AJ, Zelicof SB, Horowitz HW. Current concepts review. Prophylactic use of antibiotics for procedures after total joint replacement. J. Bone Joint Surg Am. 1996; 78: 1755-70.
31. Costerton JW. Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284: 1318-22.
32. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Infect. 2002; 15: 167-93.
33. Gristina AG, Costerton JW. Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis to biomaterials. J. Bone Joint Surg. Am. 2009; 67: 264-73.
34. Schwank S, Rajacic Z, Zimmerli W, Blaser J. Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob. Agents Chemother. 1998; 42: 895-8.
35. Jones SM, Morgan M, Humphrey TJ, Lappin-Scott H. Effect of vancomycin and rifampicin on meticillin-resistant Staphylococcus aureus biofilms. Lancet. 2001; 357: 40-1.
36. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001; 358: 135-8.
37. Monzon M, Oteiza C, Leiva J, Lamata M, Amorena B. Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. Diagn. Microbiol. Infect. Dis. 2002; 44: 319-24.
38. Inman RD, Gallegos KV, Brause BD, Redecha PB, Christian CL. Clinical and microbial features of prosthetic joint infection. Am. J. Med. 1984; 77: 47-53.
39. Del Pozo JL, Patel R. Infection associated with prosthetic joints. N. Engl. J. Med. 2009; 361: 787-94.
40. Canner GC, Steinberg ME, Heppenstall RB, Balderston R. The infected hip after total hip arthroplasty. J. Bone Joint Surg. Am. 1984; 66: 1393-9.
41. Topolski MS, Chin PYK, Sperling JW, Cofield RH. Revision shoulder arthroplasty with positive intraoperative cultures: the value of preoperative studies and intraoperative histology. J. Shoulder Elbow Surg. 2002; 15: 402-6.
42. Shih L-Y, Wu J-J, Yanc D-J. Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasty. Clin. Orthop. Relat. Res. 1987; 225: 238-46.
43. Spangehl MJ, Masri BA, Connell JXO, Duncan CP. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J. Bone Joint Surg. Am. 1999; 81: 672-83.
44. Ghanem E, Antoci V, Pulido L, Joshi A, Hozack W, Parvizi J. The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty. Int. J. Infect. Dis. 2009; 13: e444-9.
45. Bottner F, Wegner A, Winkelmann W, Becker K, Erren M, Gotze C. Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. J. Bone Joint Surg. Br. 2007; 89: 94-9.
46. Trampuz A, Hanssen AD, Osmon DR, Mandrekar J, Steckelberg JM, Patel R. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am. J. Med. 2004; 117: 556-62.
47. Shah K, Mohammed A, Patil S, McFadyen A, Meek RMD. Circulating cytokines after hip and knee arthroplasty: a preliminary study. Clin. Orthop. Relat. Res. 2009; 467: 946-51.
48. Santavirta S, Konttinen YT, Nordstrom D, Bergroth V, Antti-Poika I, Eskola A. Immune-inflammatory response in infected arthroplasties. Acta Orthop. Scand. 1989; 60: 116-8.
49. Miller TT. Imaging of knee arthroplasty. Eur. J. Radiol. 2005; 54: 164-77.
50. Smith SL, Wastie ML, Forster I. Radionuclide bone scintigraphy in the detection of significant complications after total knee joint replacement. Clin. Radiol. 2001; 56: 221-4.
51. Kwee TC, Kwee RM, Alavi A. FDG-PET for diagnosing prosthetic joint infection: systematic review and metaanalysis. Eur. J. Nucl. Med. Mol. Imaging. 2008; 35: 2122-32.
52. Cyteval C, Hamm V, Sarrabere MP, Lopez FM, Maury P, Taourel P. Painful infection at the site of hip prosthesis: CT imaging. Radiology. 2002; 224: 477-83.
53. Palestro CJ, Love C, Miller TT. Infection and musculoskeletal conditions: imaging of musculoskeletal infections. Best Pract. Res. Clin. Rheumatol. 2006; 20: 1197-218.
54. Frances Borrego A, Martinez FM, Cebrian Parra JL, Graneda DS, Crespo RG, Lopez-Duran Stern L. Diagnosis of infection in hip and knee revision surgery: intraoperative frozen section analysis. Int. Orthop. 2007; 31: 33-7.
55. Mirra JM, Amstutz HC, Matos M, Gold R. The pathology of the joint tissues and its clinical relevance in prosthesis failure. Clin. Orthop. Relat. Res. 1976; 117: 221-40.
56. Atkins BL, Athanasou N, Deeks JJ etal. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. J. Clin. Microbiol. 1998; 36: 2932-9.
57. Schafer P, Fink B, Sandow D, Margull A, Berger I, Frommelt L. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin. Infect. Dis. 2008; 47: 1403-9.
58. Trampuz A, Piper KE, Jacobson MJ etal. Sonication of removed hip and knee prostheses for diagnosis of infection. N. Engl. J. Med. 2007; 357: 654-63.
59. Amann R, Fuchs BM. Single-cell identification in microbial communities by improved fluorescence in situ hybridization techniques. Nat. Rev. Microbiol. 2008; 6: 339-48.
60. Hoeffel DP, Hinrichs SH, Garvin KL. Molecular diagnostics for the detection of musculoskeletal infection. Clin. Orthop. Relat. Res. 1999; 360: 37-46.
61. Mariani BD, Martin DS, Levine MJ, Booth RE, Tuan RS. The Coventry Award. Polymerase chain reaction detection of bacterial infection in total knee arthroplasty. Clin. Orthop. Relat. Res. 1996; 331: 11-22.
62. Clarke MT, Roberts CP, Lee PTH, Gray J, Keene GS, Rushton N. Polymerase chain reaction can detect bacterial DNA in aseptically loose total hip arthroplasties. Clin. Orthop. Relat. Res. 2004; 427: 132-7.
63. Moter A, Gobel UB. Fluorescence in situ hybridization (FISH) for direct visualization of microorganisms. J. Microbiol. Methods 2000; 41: 85-112.
64. McDowell A, Patrick S. Evaluation of nonculture methods for the detection of prosthetic hip biofilms. Clin. Orthop. Relat. Res. 2005; 437: 74-82.
65. Krimmer V, Merkert H, von Eiff C. Detection of Staphylococcus aureus and Staphylococcus epidermidis in clinical samples by 16S rRNA-directed in site hybridization. J. Clin. Microbiol. 1999; 37: 2667-73.
66. Tunney MM, Patrick S, Curran MD etal. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J. Clin. Microbiol. 1999; 37: 3281-90.
67. Bengtson S, Knutson K, Lidgren L. Treatment of infected knee arthroplasty. Clin. Orthop. Relat. Res. 1989; 245: 173-8.
68. Johnson DP, Bannister GC. The outcome of infected arthroplasty of the knee. J. Bone Joint Surg. Br. 1986; 68: 289-289.
69. Trampuz A, Zimmerli W. Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis. Curr. Infect. Dis. Rep. 2008; 10: 394-403.
70. Miley GB, Scheller AD, Turner RH. Medical and surgical treatment of the septic hip with one-stage revision arthroplasty. Clin. Orthop. Relat. Res. 1982; 170: 76-76.
71. Morscher E, Babst R, Jenny H. Treatment of infected joint arthroplasty. Int. Orthop. 1990; 14: 161-5.
72. Buchholz HW, Elson RA, Heinert K. Management of deep infection of total hip replacement. J. Bone Joint Surg. Br. 1981; 63: 342-53.
73. Salvati EA, Chekofsky KM, Brause BD, Jr PDW. Antibiotic-loaded acrylic cement: current concepts. Clin. Orthop. Relat. Res. 1984; 190: 96-96.
74. Raut VV, Siney PD, Wroblewski BM. One-stage revision of total hip arthroplasty for deep infection. Clin. Orthop. Relat. Res. 1995; 321: 202-7.
75. Jackson WO, Schmalzried TP. Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin. Orthop. Relat. Res. 2000; 381: 101-5.
76. Cherney DL, Amstutz HC. Total hip replacement in the previously septic hip. J. Bone Joint Surg. Am. 1983; 65: 1256-65.
77. Colyer RA, Capello WN. Surgical treatment of the infected hip implant. Clin. Orthop. Relat. Res. 1994; 298: 75-9.
78. Carlsson AS, Josefsson G, Lindberg L. Revision with gentamicin-impregnated cement for deep infections in total hip arthroplasties deep with gentamicin-impregnated cement infections in total hip arthroplasties. J. Bone Joint Surg. Am. 1978; 60: 1059-64.
79. Biring GS, Kostamo T, Garbuz DS, Masri BA, Duncan CP. Two-stage revision arthroplasty of the hip for infection using an interim articulated Prostalac hip spacer: a 10- to 15-year follow-up study. Journal of Bone and Joint Surgery: British Volume. 2009; 91: 1431-7.
80. Harle A. Infection management in total hip replacement. Arch. Orthop. Trauma Surg. 1989; 108: 63-71.
81. Goksan SB, Freeman MA. One-stage reimplantation for infected total knee arthroplasty. J. Bone Joint Surg. Br. 1992; 74: 78-82.
82. Scott IR, Stockley I, Getty CJM. Exchange arthroplasty for infected knee replacements. J. Bone Joint Surg. Br. 1993; 75: 28-31.
83. Buechel FF, Femino FP, D'Alessio J. Primary exchange revision arthroplasty for infected total knee replacement: A long-term study. Am. J. Orthoped. 2004; 33: 190-8.
84. Morrey BF, Westholm F, Schoifet S, Rand JA, Bryan RS. Long-term results of various treatment options for infected total knee arthroplasty. Clin. Orthop. Relat. Res. 1989; 248: 120-8.
85. Windsor RE, Insall JN, Urs WK, Miller DV, Brause BD. Two-stage reimplantation for the salvage of total knee arthroplasty complicated by infection. Further follow-up and refinement of indications. J. Bone Joint Surg. Am. 1990; 72: 272-8.
86. Wasielewski RC, Barden RM, Rosenberg AG. Results of different surgical procedures on total knee arthroplasty infections. J. Arthroplasty 1996; 11: 931-8.
87. Hanssen AD, Rand JA, Osmon DR. Treatment of the infected total knee arthroplasty with insertion of another prosthesis: the effect of antibiotic-impregnated bone cement. Clin. Orthop. Relat. Res. 1994; 309: 44-44.
88. Haleem AA, Berry DJ, Hanssen AD. The Chitranjan Ranawat Award: mid-term to long-term followup of two-stage reimplantation for infected total knee arthroplasty. Clin. Orthop. Relat. Res. 2004; 428: 35-9.
89. Meek RMD, Dunlop D, McGraw R, Masri BA. Patient satisfaction and functional status after aseptic versus septic revision total knee arthroplasty using the PROSTALAC articulating spacer. J. Arthroplasty. 2004; 19: 874-9.
90. Langlais F. Can we improve the results of revision arthroplasty for infected total hip replacement? J. Bone Joint Surg. Br. 2003; 85: 637-40.
91. Laffer RR, Graber P, Ochsner PE, Zimmerli W. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin. Microbiol. Infect. 2006; 12: 433-9.
92. Brandt CM, Sistrunk WW, Duffy MC etal. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin. Infect. Dis. 1997; 24: 914-9.
93. Crockarell JR, Hanssen AD, Osmon DR, Morrey BF. Treatment of infection with debridement and retention of the components following hip arthroplasty. J. Bone Joint Surg. Am. 1998; 80: 1306-13.
94. Deirmengian C, Greenbaum J, Lotke PA, Booth RE, Lonner JH. Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. J. Arthroplasty. 2003; 18: 22-6.
95. Widmer AF, Frei R, Rajacic Z, Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J. Infect. Dis. 1990; 162: 96-102.
96. Widmer AF, Wiestner A, Frei R, Zimmerli W. Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob. Agents Chemother. 1991; 35: 741-6.
97. Widmer AF, Gaechter A, Ochsner PE, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin. Infect. Dis. 1992; 14: 1251-3.
98. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob. Agents Chemother. 1993; 37: 1214-8.
99. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. J. Am. Med. Assoc. 1998; 279: 1537-41.
100. Drancourt M, Stein A, Argenson JN. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J. Antimicrob. Chemother. 1997; 39: 235-40.
101. Aboltins CA, Page MA, Buising KL, Jenney AWJ, Daffy JR, Choong PFM. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid. Clin. Microbiol Infect. 2007; 13: 586-91.
102. Segreti J, Nelson JA, Trenholme GM. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin. Infect Dis. 1998; 27: 711-3.
103. Kalmeijer MD etal. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin. Infect. Dis. 2002; 35: 353-8.
104. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am. J. Surg. 2005; 189: 395-404.
105. Hill C, Flamant R, Mazas F, Evrard J. Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomised trial. Lancet. 1981; 1: 795-7.
106. Engesaeter LB, Lie SA, Espehaug B, Furnes O, Vollset SE, Havelin LI. Acta Orthopaedica Scandinavica Award article 2003 antibiotic prophylaxis in total hip arthroplasty effects of antibiotic prophylaxis systemically and in bone cement on years in the Norwegian Arthroplasty Register. Acta Orthop. Scand. 2003; 74: 644-51.
107. Hope PG, Kirstinsson KG, Norman P, Elson RA. Deep infection of cemented total hip arthoplasties caused by coagulase-negative staphylococci. J. Bone Joint Surg Br. 1989; 71: 851-5.
108. Sanzen L, Walder M. Antibiotic resistance of coagulase-negative staphylococci in an orthopaedic department. J. Hosp. Infect. 1988; 12: 103-8.
109. Cummins JS, Tomek IM, Kantor SR, Furnes O, Engesaeter LB, Finlayson SRG. Cost-effectiveness of antibiotic-impregnated bone cement used in primary total hip arthroplasty. J. Bone Joint Surg. Am. 2009; 91: 634-41.
110. Lidwell OM, Lowbury EJ, Whyte W, Blowers R, Stanley SJ, Lowe D. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. Br. Med. J. (Clin. Res. Ed.) 1982; 285: 10-4.
111. Salvati EA, Robinson RP, Zeno SM, Koslin BL, Brause BD, Wilson PD. Infection rates after 3175 total hip and total knee replacements performed with and without a horizontal unidirectional filtered air-flow system. J. Bone Joint Surg. Am. 1982; 64: 525-35.
112. Brandt C, Hott U, Sohr D, Daschner F, Gastmeier P, Ruden H. Operating room ventilation with laminar airflow shows no protective effect on the surgical site infection rate in orthopedic and abdominal surgery. Ann. Surg. 2008; 248: 695-700.
113. Wahl MJ. Myths of dental-induced prosthetic joint infections. Clin. Infect. Dis. 1995; 20: 1420-5.
114. Infectious Diseases Expert Group. Prevention of infection in joint prostheses. Therapeutic Guidelines: Antibiotics Version 13. Melbourne: Therapeutic Guidelines Ltd., 2006; 35-43.